# Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload

> **NCT05440487** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 489 (actual)

## Conditions studied

- Chronic Iron Overload

## Interventions

- **OTHER:** Iron chelator

## Key facts

- **NCT ID:** NCT05440487
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-15
- **Primary completion:** 2021-10-29
- **Final completion:** 2021-10-29
- **Target enrollment:** 489 (ACTUAL)
- **Last updated:** 2022-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05440487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05440487, "Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05440487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*